Why HELP? Cybin Inc. Analysis, Price & AI Insights | Whystock
HELP
$5.15-0.16 (-3.01%)
Market ClosedLast close May 1
Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.